Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 23, 2025 04:35 ET | Source: PCI Biotech Holding ASA

PCI Biotech update

Oslo (Norway), 23 October 2025 – PCI Biotech (OSE: PCIB) today provides an update on the ongoing evaluation of its operations. Reference is made to the company’s announcements dated 18th August 2025...
September 25, 2025 09:36 ET | Source: PCI Biotech Holding ASA

PCI Biotech update on future operations

Oslo (Norway), 25 September 2025 – PCI Biotech (OSE:PCIB) today announces an update on the ongoing evaluation of its future operations. Reference is made to the announcement on 18th August 2025...
August 29, 2025 01:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech half-year interim 2025 report

Oslo (Norway), 29 August 2025 – PCI Biotech (OSE: PCIB), today announces its half-yearly 2025 interim report. Please find enclosed the interim report and presentation. Highlights review ...
August 26, 2025 10:15 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Invitation to first half 2025 results presentation and corporate update

Oslo, Norway, 26 August 2025 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2025 interim report on Friday, 29 August 2025, 08:30am – 09:00am CET (local time). ...
August 22, 2025 08:15 ET | Source: PCI Biotech Holding ASA

Flaggemelding

Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag solgt 2 000 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS ingen aksjer i PCI Biotech Holding...
August 22, 2025 05:09 ET | Source: PCI Biotech Holding ASA

Flaggemelding

Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag kjøpt 240 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS 2 000 000 aksjer, noe som utgjør 5,36%...
August 18, 2025 14:40 ET | Source: PCI Biotech Holding ASA

PCI Biotech announces discontinuation of development of the PCL technology and evaluation of future operations

Oslo (Norway), 18 August 2025 – PCI Biotech Holding ASA (PCI Biotech, OSE:PCIB) today announces the discontinuation of development of the photochemical lysis (PCL) technology for viral vector...
May 22, 2025 05:45 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Minutes of Annual General Meeting 2025

Oslo, 22 May 2025. The Annual General Meeting in PCI Biotech Holding ASA took place today, 22 May 2025. All the matters on the agenda were approved and the minutes of the Annual General Meeting are...
May 20, 2025 16:09 ET | Source: PCI Biotech Holding ASA

PCI BIotech: Disclosure of voting rights for Chair of the Board

Oslo, 20 May 2025. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter Bøhn, Chair of the Board of Directors. Hans Peter Bøhn is chair of PCI...
April 30, 2025 04:00 ET | Source: PCI Biotech Holding ASA

Notice of Annual General Meeting 2025

Oslo, Norway, 30 April 2025 - The annual general meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer Cluster Innovation Park on 22 May 2025 at 10:00am (CEST). The...